Pictet Asset Management Sa Atai Life Sciences N.V. Call Options Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ATAI
# of Institutions
125Shares Held
33.5MCall Options Held
494KPut Options Held
315K-
Ubs Group Ag7.7MShares$34.1 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.43MShares$24.1 Million0.02% of portfolio
-
Morgan Stanley New York, NY3.49MShares$15.5 Million0.0% of portfolio
-
Pale Fire Capital Se Prague, 2N2.64MShares$11.7 Million0.59% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.02MShares$8.95 Million0.07% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $735M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...